IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $244 | -100.0% | 5,956 | -79.8% | 0.00% | -87.5% |
| Q2 2022 | $1,091,000 | +4.7% | 29,479 | +4.8% | 0.01% | +14.3% |
| Q1 2022 | $1,042,000 | +35.9% | 28,122 | +11.5% | 0.01% | +16.7% |
| Q4 2021 | $767,000 | -7.1% | 25,217 | +2.4% | 0.01% | -14.3% |
| Q3 2021 | $826,000 | -9.1% | 24,614 | +8.0% | 0.01% | -12.5% |
| Q2 2021 | $909,000 | +1.6% | 22,786 | +14.5% | 0.01% | -11.1% |
| Q1 2021 | $895,000 | +343.1% | 19,896 | +495.0% | 0.01% | +200.0% |
| Q4 2019 | $202,000 | -1.5% | 3,344 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $205,000 | -22.9% | 3,430 | -17.0% | 0.00% | -25.0% |
| Q2 2019 | $266,000 | +6.0% | 4,134 | +33.4% | 0.00% | 0.0% |
| Q1 2019 | $251,000 | +4.1% | 3,098 | -33.6% | 0.00% | 0.0% |
| Q3 2018 | $241,000 | – | 4,669 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |